CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 52 filers reported holding CIDARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,332,000 | +49.5% | 594,705 | +34.8% | 0.01% | +50.0% |
| Q2 2021 | $891,000 | -50.4% | 441,060 | -34.7% | 0.01% | -57.1% |
| Q1 2021 | $1,796,000 | +203.9% | 675,257 | +128.4% | 0.01% | +180.0% |
| Q4 2020 | $591,000 | +172.4% | 295,611 | +237.7% | 0.01% | +66.7% |
| Q1 2020 | $217,000 | -60.9% | 87,530 | -39.5% | 0.00% | -40.0% |
| Q4 2019 | $555,000 | +118.5% | 144,609 | +50.7% | 0.01% | +25.0% |
| Q1 2019 | $254,000 | -11.2% | 95,983 | -21.1% | 0.00% | -20.0% |
| Q4 2018 | $286,000 | -45.3% | 121,677 | +2.4% | 0.01% | -28.6% |
| Q3 2018 | $523,000 | +18.9% | 118,777 | +40.3% | 0.01% | 0.0% |
| Q2 2018 | $440,000 | +5.8% | 84,677 | -18.6% | 0.01% | 0.0% |
| Q1 2018 | $416,000 | -17.3% | 104,056 | +40.8% | 0.01% | -22.2% |
| Q4 2017 | $503,000 | +24.2% | 73,917 | +47.7% | 0.01% | +12.5% |
| Q3 2017 | $405,000 | -15.8% | 50,056 | -22.0% | 0.01% | -20.0% |
| Q2 2017 | $481,000 | – | 64,168 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |